https://odysseytx.com/odyssey-therapeutics-announces-oversubscribed-213-million-series-d-financing-to-advance-clinical-pipeline-for-autoimmune-diseases/

Odyssey Therapeutics Announces Oversubscribed $213 Million Series D Financing to
Advance Clinical Pipeline for Autoimmune Diseases